Table 5 Proposal for discontinuation of combined therapy with PD and HD
From: Clinical efficacy of combined therapy with peritoneal dialysis and hemodialysis
1. Insufficient solute removal (inadequate dialysis) |
β2 microglobulin >35 mg/L |
Other uremic symptoms |
Deterioration of nutritional status, decreased SGA, persistent anorexia |
ESA-hyporesponsive anemia |
Restless legs syndrome |
2. Insufficient fluid removal (fluid overload) |
Higher or drug-resistant blood pressure |
Heart enlargement or pleural effusion on chest X-rays |
Persistent peripheral edema, anasarca |
3. Consideration of the risk of development of EPS |
Prolonged PD duration |
Frequent PD-associated peritonitis |
Higher D/P Cr |